• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物理射频佐剂增强了对 H5N1 流感疫苗的免疫反应。

Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination.

机构信息

Biomedical & Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.

Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.

出版信息

FASEB J. 2022 Mar;36(3):e22182. doi: 10.1096/fj.202101703R.

DOI:10.1096/fj.202101703R
PMID:35113455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928172/
Abstract

Pre-pandemic influenza H5N1 vaccine has relatively low immunogenicity and often requires high antigen amounts and two immunizations to induce protective immunity. Incorporation of vaccine adjuvants is promising to stretch vaccine doses during pandemic outbreaks. This study presents a physical radiofrequency (RF) adjuvant (RFA) to conveniently and effectively increase the immunogenicity and efficacy of H5N1 vaccine without modification of vaccine preparation. Physical RFA is based on a brief RF treatment of the skin to induce thermal stress to enhance intradermal vaccine-induced immune responses with minimal local or systemic adverse reactions. We found that physical RFA could significantly increase H5N1 vaccine-induced hemagglutination inhibition antibody titers in murine models. Intradermal H5N1 vaccine in the presence of RFA but not vaccine alone significantly lowered lung viral titers, reduced body weight loss, and improved survival rates after lethal viral challenges. The improved protection in the presence of RFA was correlated with enhanced humoral and cellular immune responses to H5N1 vaccination in both male and female mice, indicating no gender difference of RFA effects in murine models. Our data support further development of the physical RFA to conveniently enhance the efficacy of H5N1 vaccine.

摘要

大流行前的 H5N1 流感疫苗的免疫原性相对较低,通常需要高剂量抗原和两次免疫接种才能诱导保护性免疫。在大流行爆发期间,疫苗佐剂的结合有望延长疫苗剂量。本研究提出了一种物理射频(RF)佐剂(RFA),可方便有效地提高 H5N1 疫苗的免疫原性和功效,而无需对疫苗制备进行修饰。物理 RFA 基于皮肤的短暂射频处理,以诱导热应激,从而增强皮内疫苗诱导的免疫反应,而局部或全身不良反应最小。我们发现,物理 RFA 可显著提高小鼠模型中 H5N1 疫苗诱导的血凝抑制抗体滴度。在存在 RFA 的情况下,皮内 H5N1 疫苗而不是单独的疫苗可显著降低肺部病毒滴度、减轻体重减轻,并提高致命病毒攻击后的存活率。RFA 存在时改善的保护与 H5N1 疫苗接种后体液和细胞免疫反应的增强相关,这表明 RFA 对小鼠模型的影响没有性别差异。我们的数据支持进一步开发物理 RFA 以方便地增强 H5N1 疫苗的功效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/9e274050592d/nihms-1786013-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/45ed7d246c23/nihms-1786013-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/03634b8f5c41/nihms-1786013-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/bbf05fcf0beb/nihms-1786013-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/80876426e7a0/nihms-1786013-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/b2ca153a96c3/nihms-1786013-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/71218e399ed3/nihms-1786013-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/b90f898d2104/nihms-1786013-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/9e274050592d/nihms-1786013-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/45ed7d246c23/nihms-1786013-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/03634b8f5c41/nihms-1786013-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/bbf05fcf0beb/nihms-1786013-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/80876426e7a0/nihms-1786013-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/b2ca153a96c3/nihms-1786013-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/71218e399ed3/nihms-1786013-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/b90f898d2104/nihms-1786013-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ea/8928172/9e274050592d/nihms-1786013-f0008.jpg

相似文献

1
Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination.物理射频佐剂增强了对 H5N1 流感疫苗的免疫反应。
FASEB J. 2022 Mar;36(3):e22182. doi: 10.1096/fj.202101703R.
2
A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.一种阳离子脂质体-DNA复合物佐剂(JVRS-100)可增强雪貂体内大流行前甲型流感病毒(H5N1)疫苗的免疫原性和交叉保护效力。
Virology. 2016 May;492:197-203. doi: 10.1016/j.virol.2016.02.024. Epub 2016 Mar 21.
3
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.经鼻递送含Protollin佐剂的H5N1疫苗可增强小鼠的全身及黏膜免疫。
Vaccine. 2017 Jun 5;35(25):3318-3325. doi: 10.1016/j.vaccine.2017.05.004. Epub 2017 May 9.
4
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice.MF59 佐剂全灭活 H5N1 流感疫苗在 1 型糖尿病小鼠中提供的优越保护。
Arch Virol. 2011 Mar;156(3):387-95. doi: 10.1007/s00705-010-0860-4. Epub 2010 Nov 26.
5
Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.MF59(®)佐剂的 A/H5N1 大流行前流感疫苗在成年人和老年人中的安全性和免疫原性。
Vaccine. 2012 Feb 8;30(7):1388-96. doi: 10.1016/j.vaccine.2011.12.009. Epub 2011 Dec 20.
6
A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets.单次免疫 CoVaccine HT 佐剂 H5N1 流感病毒疫苗可诱导雪貂产生保护性细胞和体液免疫应答。
J Virol. 2010 Aug;84(16):7943-52. doi: 10.1128/JVI.00549-10. Epub 2010 Jun 2.
7
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice.阳离子脂质体-DNA 复合物 (CLDC) 佐剂增强了小鼠对大流行性流感 A H5N1 疫苗的免疫原性和交叉保护效力。
Vaccine. 2012 Jan 5;30(2):254-64. doi: 10.1016/j.vaccine.2011.10.103. Epub 2011 Nov 12.
8
Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.纳米乳剂佐剂的重组 H5 血凝素可保护雪貂免受致病性禽流感病毒的挑战。
Vaccine. 2019 Mar 14;37(12):1591-1600. doi: 10.1016/j.vaccine.2019.02.002. Epub 2019 Feb 19.
9
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素(HA)和重组霍乱毒素B亚单位(CTB)作为佐剂,对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
10
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.使用结构优化的RIG-I激动剂作为佐剂增强流感病毒样颗粒疫苗接种。
J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

引用本文的文献

1
Comparative tissue proteomics reveals unique action mechanisms of vaccine adjuvants.比较组织蛋白质组学揭示了疫苗佐剂的独特作用机制。
iScience. 2022 Dec 14;26(1):105800. doi: 10.1016/j.isci.2022.105800. eCollection 2023 Jan 20.
2
Emerging adjuvants for intradermal vaccination.新型皮内佐剂疫苗。
Int J Pharm. 2023 Feb 5;632:122559. doi: 10.1016/j.ijpharm.2022.122559. Epub 2022 Dec 28.
3
Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvant.

本文引用的文献

1
Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant.物理射频佐剂增强重组核蛋白和M1诱导的细胞免疫反应及保护作用
Vaccines (Basel). 2021 Nov 24;9(12):1382. doi: 10.3390/vaccines9121382.
2
Brief exposure of skin to near-infrared laser augments early vaccine responses.皮肤短暂暴露于近红外激光可增强早期疫苗反应。
Nanophotonics. 2021 Sep;10(12):3187-3197. doi: 10.1515/nanoph-2021-0133. Epub 2021 Aug 9.
3
BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection.
物理射频佐剂有效增强纳克级流感疫苗并诱导交叉保护免疫。
Sci Rep. 2022 Dec 8;12(1):21249. doi: 10.1038/s41598-022-25605-4.
4
Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant.使用CpG 1018佐剂克服与衰老相关的流感疫苗反应不佳问题。
Vaccines (Basel). 2022 Nov 10;10(11):1894. doi: 10.3390/vaccines10111894.
卡介苗细胞壁骨架作为疫苗佐剂可保护幼龄和老龄小鼠免受流感病毒感染。
Biomedicines. 2021 May 5;9(5):516. doi: 10.3390/biomedicines9050516.
4
Vaccine delivery alerts innate immune systems for more immunogenic vaccination.疫苗递送可激活先天免疫系统,实现更具免疫原性的疫苗接种。
JCI Insight. 2021 Apr 8;6(7):144627. doi: 10.1172/jci.insight.144627.
5
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity.流感疫苗的佐剂化以诱导交叉保护性免疫。
Vaccines (Basel). 2021 Jan 21;9(2):75. doi: 10.3390/vaccines9020075.
6
Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.新兴和再现病毒性传染病疫苗研发的成功率和时间表。
Ann Intern Med. 2021 Mar;174(3):326-334. doi: 10.7326/M20-5350. Epub 2020 Nov 24.
7
Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.含保守神经氨酸酶或 M2 胞外结构域表位嵌合血凝素缀合物的灭活重组流感病毒的交叉保护作用。
Virology. 2020 Nov;550:51-60. doi: 10.1016/j.virol.2020.08.003. Epub 2020 Aug 22.
8
The 1918 influenza pandemic: 100 years of questions answered and unanswered.1918 年流感大流行:百年未解之谜。
Sci Transl Med. 2019 Jul 24;11(502). doi: 10.1126/scitranslmed.aau5485.
9
Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.神经氨酸酶表达的病毒样颗粒疫苗为流感病毒提供了有效的交叉保护。
Virology. 2019 Sep;535:179-188. doi: 10.1016/j.virol.2019.07.008. Epub 2019 Jul 8.
10
Viroporins in the Influenza Virus.流感病毒中的病毒离子通道蛋白
Cells. 2019 Jun 29;8(7):654. doi: 10.3390/cells8070654.